Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer

about

Risk Factors and Preventions of Breast Cancer.PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer.

P2860

Q47100005-56B72CCE-841B-4976-ACF0-1348133E8E0D Q47271622-7247E498-059D-4E78-9E44-29531A87D3BB

P2860

Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer

Item

http://www.wikidata.org/entity/Q40953806

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer

@en

type

Item

label

Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer

@en

prefLabel

Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer

@en

P1476

Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer

@en

P2093

Aeri Kim

http://www.w3.org/2001/XMLSchema#string

Min Hye Jang

http://www.w3.org/2001/XMLSchema#string

Soo Jung Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular pathology of lung cancer: key to personalized medicine.

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

A perspective on anti-EGFR therapies targeting triple-negative breast cancer

Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers

Immunohistochemical staining with EGFR mutation-specific antibodies: high specificity as a diagnostic marker for lung adenocarcinoma

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

Spectrum of EGFR gene copy number changes and KRAS gene mutation status in Korean triple negative breast cancer patients.

Pyrosequencing, a method approved to detect the two major EGFR mutations for anti EGFR therapy in NSCLC.

Amplified cellular oncogenes in neoplasms of the human central nervous system.

Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy.

P304

150-159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4048/JBC.2017.20.2.150

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Y K Bae

P577

2017-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28690651

http://www.w3.org/2001/XMLSchema#string

P932

5500398

http://www.w3.org/2001/XMLSchema#string

Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer

about

P2860

P2860

Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932